No results were found for your search. Please adjust your search term or broaden your search criteria.
Still can't find what you are looking for? We can prepare Custom Research for you.
Mozobil is a drug used to treat lymphoma, a type of cancer that affects the lymphatic system. It is a type of monoclonal antibody, which works by targeting and blocking a protein called CD-117, which is found on the surface of certain types of cancer cells. Mozobil is used in combination with other drugs to treat certain types of lymphoma, including diffuse large B-cell lymphoma (DLBCL). It is also used to help patients prepare for a stem cell transplant.
Mozobil is a relatively new drug, and is not yet widely available. It is currently approved for use in the United States, Canada, and Europe. It is marketed by Sanofi Genzyme, a subsidiary of Sanofi.
The Mozobil market is made up of a number of companies, including Sanofi Genzyme, Celgene, Novartis, and Pfizer. These companies are involved in the research, development, and marketing of Mozobil and other lymphoma drugs. Other companies, such as Merck, are also involved in the development of new treatments for lymphoma. Show Less Read more
